Evidence map›Paper›PMID 35779279›Full record

ArticleTransactions of the Royal Society of Tropical Medicine and Hygiene2023

Persistence of Trypanosoma cruzi vector-borne transmission among school-age children in the Bolivian Chaco documented by 24-month longitudinal serosurveillance.

Michele Spinicci, Fabio Macchioni, Herlan Gamboa, Veronica Poma, Ana Liz Villagrán, Marianne Strohmeyer, Mimmo Roselli, Roberto Vargas, Alessandro Bartoloni, Simona Gabrielli

Open access · hybridAbstract read
In one paragraph

Article in Transactions of the Royal Society of Tropical Medicine and Hygiene, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 20 citations in OpenAlex.

  1. Seroprevalence Patterns Suggestive of PostnatalTropical medicine and infectious disease · 2026
    Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 8 institutions in 3 countries.

Michele SpinicciDipartimento di Medicina Sperimentale e Clinica, Università degli Studi di Firenze, Firenze, Italy.ORCID 0000-0002-5377-7118
Fabio MacchioniDipartimento di Scienze Veterinarie, Università di Pisa, Pisa, Italy.
Herlan GamboaFacultad Integral del Chaco, Universidad Autónoma Gabriel René Moreno, Camiri, Bolivia.
Veronica PomaEscuela de Salud del Chaco Tekove Katu, Gutierrez, Bolivia.
Ana Liz VillagránHospital Básico de Villa Montes, Villa Montes, Bolivia.
Marianne StrohmeyerDipartimento di Medicina Sperimentale e Clinica, Università degli Studi di Firenze, Firenze, Italy.
Mimmo RoselliDipartimento di Medicina Sperimentale e Clinica, Università degli Studi di Firenze, Firenze, Italy.
Roberto VargasServicio Departamental de Salud de Santa Cruz, Santa Cruz, Bolivia.
Alessandro BartoloniDipartimento di Medicina Sperimentale e Clinica, Università degli Studi di Firenze, Firenze, Italy.
Simona GabrielliDipartimento di Sanità Pubblica e Malattie infettive, Università di Roma Sapienza, Roma, Italy.
Azienda Ospedaliero-Universitaria Careggi · ITUniversity of Florence · ITGabriel René Moreno Autonomous University · BOHospital Montecelo · ESMinisterio de Salud · BOSapienza University of Rome · ITUniversidad Privada Del Chaco · BOUniversity of Pisa · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChagas disease represents a major public health concern in several Latin American countries, including Bolivia.

methodsWe present a longitudinal serosurvey for Trypanosoma cruzi antibodies among a cohort of 120 school-age children from rural communities in the Bolivian Chaco at three time points between 2017 and 2019. Serum samples extracted from dry blood spots collected on filter paper were tested for T. cruzi antibodies by enzyme-linked immunosorbent assay and rapid diagnostic test.

resultsT. cruzi antibodies were detected in 7/120 (5.8%), 8/120 (6.7%) and 11/120 (9.2%) samples in 2017, 2018 and 2019, respectively. An average incidence of 1.76 per 100 person-years was observed.

conclusionsOur findings support the persistence of vector-borne T. cruzi transmission in this area, highlighting the need for strengthening multidisciplinary efforts against Chagas disease.

Indexed as

Chagas DiseaseTrypanosoma cruziAntibodies, ProtozoanBoliviaChildEnzyme-Linked Immunosorbent AssayHumansAntibodies, ProtozoanBoliviaChagas diseaseprevalenceserologic testsserology

Identifiers

PMID35779279
PMCPMC9808515
OpenAlexW4283785366

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.